4//SEC Filing
Wirostko Barbara 4
Accession 0001144204-19-034764
CIK 0001372514other
Filed
Jul 14, 8:00 PM ET
Accepted
Jul 15, 8:38 PM ET
Size
10.3 KB
Accession
0001144204-19-034764
Insider Transaction Report
Form 4
Wirostko Barbara
Chief Medical Officer
Transactions
- Sale
Common Stock
2019-07-12$0.24/sh−6,488$1,529→ 412,022 total - Sale
Common Stock
2019-07-11$0.24/sh−6,487$1,561→ 418,510 total - Sale
Common Stock
2019-07-15$0.23/sh−6,488$1,512→ 405,534 total
Holdings
- 59,915(indirect: By Spouse)
Common Stock
Footnotes (4)
- [F1]Sale of shares to cover taxes due on restricted stock that vested on 07/10/2019.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.24 to $0.245, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.2257 to $0.24, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.227 to $0.2403, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4.
Documents
Issuer
EYEGATE PHARMACEUTICALS INC
CIK 0001372514
Entity typeother
Related Parties
1- filerCIK 0001669087
Filing Metadata
- Form type
- 4
- Filed
- Jul 14, 8:00 PM ET
- Accepted
- Jul 15, 8:38 PM ET
- Size
- 10.3 KB